The Executive has created a new special interest group forum for discussions on COVID-19. Members can now request access.
The organising committee of the 14th meeting of the Asia Pacific Federation of Pharmacologists have this week announced the change of date of the APFP meeting to September 27-30 2020. Click here to find out more. http://2020apfp.com/
It is with great sadness the ASCEPT Executive notify you that Professor Sir Alasdair Breckenridge passed away on 13 December 2019. He had been a member of BPS since 1971 and was elected to Honorary Fellowship in 2002. His contribution to the Society was longstanding, as was his contribution to clinical pharmacology. He was also a major influence on UK regulatory pharmacology. The BPS will be publishing an obituary shortly but in the meantime they encourage you to watch Sir Alasdair discuss his life and work in an interview with President-Elect, Professor Sir Munir Pirmohamed. Our thoughts are with his family and friends.
Dr. Stefanie Hennig joined Certara Strategic Consulting as an Associate Director of Consulting Service in July 2019. She will be working as a consultant in PK and PK/PD modelling and simulation in various phases of drug development in a variety of population groups.
The Academy has elected 40 new Fellows, including 19 women, and will discuss the global pandemic threat at its annual meeting. The Australian Academy of Health and Medical Sciences has elected 40 new Fellows...
Leading cardiovascular disease researcher Professor Rebecca Ritchie has been appointed as the new Theme Leader of the Drug Discovery Biology Theme in the Monash Institute of Pharmaceutical Sciences (MIPS). Professor Ritchie is currently an NHMRC Senior Research Fellow and Head of the Heart Failure Laboratory at the Baker Heart and Diabetes Institute.
Professor Jason Roberts from the UQ School of Pharmacy has been recognised as one of the country's leading researchers. The Australian’s 2019 Research magazine has named Professor Roberts as Australia’s Leading Researcher in both Communicable Diseases and Critical Care.
Real-time decision making equals empowered students. That is the essence of SimPHARM™, a state-of-the-art simulation tool developed at the University of Otago and now commercially licensed by a United States-based company to help pharmacy students learn via a realistic clinical experience.
Professor Andrew McLachlan was made a Member in the General Division of the Order of Australia (AM) for “significant service to pharmacy as a researcher, educator and administrator, and to professional medical and scientific organisations”. Andrew was also recently appointed as the Head of School and Dean of Pharmacy at the University of Sydney. Congratulations Andrew!